IP Library Granted Patent US 7,534,799
Granted Patent B2
US 7,534,799 · App. 11/492,095 · Granted May 19, 2009

Pyridomorphinans, thienomorphinans and use thereof

Assignee: Southern Research Institute
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,534,799
App. No.
11/492,095
Granted
May 19, 2009
Kind
B2
Abstract

Compounds represented by the formulae: wherein each of Y, X and R individually is selected from the group consisting of hydrogen, hydroxy, halo, CF 3 , NO 2 , CN, NH 2 , COR 1 and CO 2 R 2 wherein R 1 is selected from the group consisting of alkyl, aryl, alkaryl, and NH 2 , and R 2 is selected from the group consisting of alkyl, aryl and aralkyl, and provided that at least one of Y, X and R is other than H; and pharmaceutically acceptable salts thereof are provided. Compounds of the above formula are useful as analgesics for treating pain, as immunomodulators and for treating drug abuse.

Claims (16)

1. A method for treating a patient suffering from pain which comprises administering to the patient a pain treating effective amount of at least one compound represented by the formulae I and II

wherein each of Y, X and R individually is selected from the group consisting of hydrogen, hydroxyl, halo, CF 3 , NO 2 , CN, NH 2 , COR 1 and CO 2 R 2 wherein R 1 is selected from the group consisting of alkyl, aryl, alkaryl, and NH 2 , and R 2 is selected from the group consisting of alkyl, aryl, and aralkyl, and provided that at least one of Y, X and R in formula I is other than hydrogen; or pharmaceutically acceptable salt thereof.

2. The method of claim 1 wherein the compound is represented by formula I wherein X is H, Y is H and R is Br.

3. The method of claim 1 wherein the compound is represented by formula I wherein X is H, Y is H and R is CN.

4. The method of claim 1 wherein the compound is represented by formula I wherein X is H, Y is H and R is CO 2 R 2 .

5. The method of claim 1 wherein the compound is represented by formula I wherein X is H, Y is H and R is NO 2 .

6. The method of claim 1 wherein the compound is represented by formula I wherein X is H, Y is H and R is NH 2 .

7. The method of claim 1 wherein the compound is represented by formula II wherein X is NH 2 , and R is H.

8. The method of claim 1 wherein the compound is represented by formula II wherein X is NH 2 , and R is CN.

9. The method of claim 1 wherein the compound is represented by formula II wherein X is NH 2 , and R is CO 2 R 2 .

10. The method of claim 1 wherein the compound is represented by formula II wherein X is NH 2 , and R is H.

11. A method for treating a patient suffering from drug abuse selected from the group consisting of cocaine abuse and methamphetamine abuse which comprises administering to the patient an effective amount for treating drug abuse of at least one compound represented by the formulae I and II

wherein each of Y, X and R individually is selected from the group consisting of hydrogen, hydroxyl, halo, CF 3 , NO 2 , CN, NH 2 , COR 1 and CO 2 R 2 wherein R 1 is selected from the group consisting of alkyl, aryl, alkaryl, and NH 2 , and R 2 is selected from the group consisting of alkyl, aryl, and aralkyl, and provided that at least one of Y, X and R in formula I is other than hydrogen; or pharmaceutically acceptable salt thereof.

12. A method for treating a patient suffering from dependence on or tolerance to a μ agent which comprise administering to the patient at least one the compound represented by the formulae I and II

wherein each of Y, X and R individually is selected from the group consisting of hydrogen, hydroxyl, halo, CF 3 , NO 2 , CN, NH 2 , COR 1 and CO 2 R 2 wherein R 1 is selected from the group consisting of alkyl, aryl, alkaryl, and NH 2 , and R 2 is selected from the group consisting of alkyl, aryl, and aralkyl, and provided that at least one of Y, X and R in formula I is other than hydrogen; or pharmaceutically acceptable salt thereof in an amount effective to modulate the tolerance to or dependence on μ agonists.

13. The method of claim 1 wherein the compound is represented by formula II wherein X is NH 2 , and R is CONH 2 .

Assignments (1)
CONFIRMATORY LICENSE Recorded Dec 9, 2024
From: SOUTHERN RESEARCH INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH
Reel/Frame 069521/0607 →
Continuity (4)
Division 1125907300 · Oct 27, 2005
Division 1004950400
Provisional Application 6014858100 · Aug 13, 1999
Related Publication 20060264452A1 · Nov 23, 2006